Drug Shortage Report for TEVA-BUDESONIDE

Last updated on 2025-05-02 History
Report ID 195478
Drug Identification Number 02465957
Brand name TEVA-BUDESONIDE
Common or Proper name TEVA-BUDESONIDE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) BUDESONIDE
Strength(s) 0.5MG
Dosage form(s) SUSPENSION
Route of administration INHALATION INHALATION
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 20
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-06-19
Estimated end date 2025-09-30
Actual end date
Shortage status Actual shortage
Updated date 2025-05-02
Company comments Product is under allocation
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2024-05-09 English Compare
v25 2024-03-28 French Compare
v24 2024-03-28 English Compare
v23 2024-03-21 French Compare
v22 2024-03-21 English Compare
v21 2024-03-14 French Compare
v20 2024-03-14 English Compare
v19 2024-01-25 French Compare
v18 2024-01-25 English Compare
v17 2024-01-18 French Compare
v16 2024-01-18 English Compare
v15 2023-11-16 French Compare
v14 2023-11-16 English Compare
v13 2023-10-26 French Compare
v12 2023-10-26 English Compare
v11 2023-10-05 French Compare
v10 2023-10-05 English Compare
v9 2023-07-27 French Compare
v8 2023-07-27 English Compare
v7 2023-07-19 French Compare

Showing 41 to 60 of 66